BLACK WEEKSFiolki −15% · zestawy −10% · reszta −5%z kodemDarmowa wysyłka na terenie Niemiec od 200 €

Ta strona została przetłumaczona automatycznie i może zawierać błędy. Polski to Twój język ojczysty? Chętnie poznamy Twoje uwagi i poprawki.Wyślij opinię

The Peptide Desk The Peptide Desk
PT-141 Nasal, zdjęcie produktu
Sexual Health

PT-141 Nasal

Sexual Health

  • Wysyłka z Niemiec

Zamówienie

Cena jedn. - Darmowa wysyłka na terenie Niemiec od 200 € w czasie Black Weeks
  • DHL ze śledzeniem
  • Dyskretne opakowanie

4.6 na 5 na Trustpilot73 opinii

Wyszukiwane też jako: PT-141 Nasenspray

W skrócie

PT-141 Nasal w liczbach

Najważniejsze dane z naszego leksykonu. Przeciągnij punkt wzdłuż krzywej, aby zobaczyć, ile zostaje po jednej dawce, według obliczeń.

Pełny wpis w leksykonie

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~2 hours

Half-life ~2 hours
After 4 hours: 25 %
Hour 250 %Hour 425 %Hour 612.5 %Hour 103.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

About2hours

after nasal dosing (1.9 to 2.1 hours), peak levels at around 30 minutes

Class
Non-selective melanocortin agonistmainly MC4R and MC1R, plus MC3R, cyclic heptapeptide, medical name: bremelanotide
Frequency
No more than once in 24 hours and no more than 8 uses per month (the label rule for the injection)
Form
Ready-made nasal spray, 10mg in 5.4ml1.85mg/ml, about 185mcg per spray, about 50 sprays
Sizes
10 mg1 size in the shop

Dla PT-141 Nasal nie ma jeszcze analizy laboratoryjnej. ZagłosujZleć test samodzielnie, zapłacimy połowęWszystkie analizy laboratoryjne

Wiedza

Wszystko o PT-141 Nasal

Szczegółowe informacje wkrótce.

Dawkowanie

Ładowanie informacji o dawkowaniu …

Więcej w leksykonie

FAQ

Najczęstsze pytania

Źródła do każdej odpowiedzi: wpis w leksykonie

Masz jeszcze pytanie?

Napisz do nas, nasz zespół Ci pomoże.

Is PT-141 approved?

Yes, as bremelanotide in the USA since 2019. The approval is narrow: women before menopause with acquired, generalised low sexual desire that causes distress. Not for men, not after menopause and according to the label not to enhance sexual performance.

How does PT-141 differ from PDE-5 inhibitors?

The point of action. PDE-5 inhibitors act via blood flow. Bremelanotide activates melanocortin receptors, including MC4R on nerve cells in the brain. How this leads to more desire is not clear according to the label.

What did the phase 3 trials show?

In two trials with 1,267 women in total, desire rose by 0.35 points more than on placebo after 24 weeks and distress fell by 0.33 points more. Both were statistically significant. In the open extension over 52 weeks the values stayed stable.

How long does PT-141 stay in the body?

After one dose under the skin the level peaks after about one hour, the half-life is about 2.7 hours. That fits use on demand, as the entry describes.

Which side effects were seen?

Most often nausea (40 percent versus 1.3 percent on placebo), facial flushing (20 percent) and headache (11 percent). Nausea was the most common reason for stopping. Blood pressure rose by a few mmHg for a short time after a dose.

What about dark patches on the skin?

Via MC1R bremelanotide stimulates pigment formation. Patchy darkening, including on the face and gums, was rare with dosing according to the label (about 1 percent). After up to 16 doses on consecutive days it occurred in more than a third and did not resolve in everyone.

Powiązane

Podobne produkty